688013 Touchstone International Medical Science Co., Ltd.
- 17.73
- -0.36-1.99%
Touchstone International Medical Science Co., Ltd. News
Tesson Healthcare (688013.SH): A total cost of 35.983,700 yuan to buy back 2.56% of the shares
Glonghui, May 7, 丨 Tesson Healthcare (688013.SH) announced that as of the close of April 30, 2024, the company had repurchased a total of 2,079,068 shares, accounting for 2.56% of the company's total share capital. The highest price of the repurchase transaction was 21.00 yuan/share, the lowest price was 11.87 yuan/share, and the total capital paid was approximately RMB 35.9837 million (excluding transaction fees such as stamp duty and transaction fees).
Tesson Healthcare (688013.SH) released 2023 annual results, with net profit of 473.112 million yuan, an increase of 9.53% over the previous year
Tesson Healthcare (688013.SH) released its 2023 annual report. The company achieved operating income of 2 during the reporting period...
Tesson Healthcare (688013.SH): A total of 2.53% of the company's shares have been repurchased
Gelonghui, April 1, 丨 Tianchen Medical (688013.SH) announced that by the close of trading on March 31, 2024, the company had repurchased 2,055,068 shares of the company through centralized bidding transactions, accounting for 2.53% of the company's total share capital. The highest price of the repurchase transaction was 21.00 yuan/share, the lowest price was 11.87 yuan/share, and the total amount of capital paid was approximately RMB 35.6376 million (excluding transaction fees such as stamp duty and transaction fees).
Touchstone International Medical Science Co., Ltd. (SHSE:688013) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Those holding Touchstone International Medical Science Co., Ltd. (SHSE:688013) shares would be relieved that the share price has rebounded 25% in the last thirty days, but it needs to keep going to re
Tesson Healthcare (688013.SH): A total of 2.53% of the company's shares have been purchased at a cost of 356.37,600 yuan
Gelonghui, March 4, 丨 Tianchen Medical (688013.SH) announced that by the close of trading on February 29, 2024, the company had repurchased 2,055,068 shares of the company through centralized bidding transactions, accounting for 2.53% of the company's total share capital. The highest price of the repurchase transaction was 21.00 yuan/share, the lowest price was 11.87 yuan/share, and the total amount of capital paid was approximately RMB 35.6376 million (excluding transaction fees such as stamp duty and transaction fees).
The net profit of Tesson Healthcare (688013.SH) in 2023 was 52.6605 million yuan, up 21.91% year-on-year
Tesson Healthcare (688013.SH) disclosed its 2023 annual results report. The company achieved operating income of 2 during the reporting period...
Tesson Healthcare (688013.SH): It has spent 307.85 million yuan to buy back 2.16% of the company's shares
Gelonghui, Feb. 7 | Tianchen Healthcare (688013.SH) announced that by the close of trading on February 7, 2024, the company had repurchased a total of 1,754,500 shares through the Shanghai Stock Exchange trading system, accounting for 2.16% of the company's total share capital, an increase of 0.80% compared with the previous disclosure. The highest price of the repurchase transaction was 21.00 yuan/share, and the lowest price was 11.87 yuan/share. The total amount of capital paid was approximately RMB 30.785 million (excluding transaction fees such as stamp duty and transaction fees).
Touchstone International Medical Science Co., Ltd.'s (SHSE:688013) Popularity With Investors Under Threat As Stock Sinks 28%
Touchstone International Medical Science Co., Ltd. (SHSE:688013) shareholders that were waiting for something to happen have been dealt a blow with a 28% share price drop in the last month. The dro
Tesson Healthcare (688013.SH): A total of 887,000 shares have been repurchased as of January 22
Gelonghui, January 22丨Tianchen Medical (688013.SH) announced that as of the close of January 22, 2024, the company had repurchased 887,000 shares of the company's shares through centralized bidding transactions through the Shanghai Stock Exchange trading system, accounting for 1.09% of the company's total share capital, an increase of 1.04% compared with the previous disclosure. The highest price of the repurchase transaction was RMB 21.00 per share, and the lowest price was RMB 17.92 per share. The total amount of capital paid was RMB 17.912 million (excluding stamp duty, trading commissions, etc.) costs).
Tesson Healthcare (688013.SH): Initial repurchase of 44,400 shares
Gelonghui, January 8, 丨 Tianchen Medical (688013.SH) announced that on January 8, 2024, the company repurchased 44,134 shares for the first time through the Shanghai Stock Exchange trading system, accounting for 0.05% of the company's total share capital of 81,155,600 shares. The highest price of the repurchase transaction was 20.90 yuan/share, the lowest price was 20.79 yuan/share, and the total amount of capital paid was RMB 919,731.41 (excluding transaction fees such as stamp duty and transaction fees).
Tesson Healthcare (688013.SH): Shares have not been repurchased
Gelonghui, January 2, 丨 Tianchen Medical (688013.SH) announced that as of December 31, 2023, the company had not repurchased shares through centralized bidding transactions through the Shanghai Stock Exchange trading system.
Tesson Healthcare: Chairman Proposes to Repurchase Shares for $18-36 Million
Glonghui, December 27 | Tianchen Medical announced that the chairman proposed to repurchase shares for 18-36 million yuan, and that the repurchase price of shares should not exceed RMB 30.00 per share.
[BT Financial Report Instantaneous Analysis] Tianchen Healthcare's 2023 Three-Quarter Report: Revenue Growth, Net Profit Steady Increase, and R&D Investment Continues to Increase
This earnings announcement time: 2023-10-27 17:01:10 Tianchen Healthcare (stock code: 688013) is an enterprise focusing on products needed at critical times of surgery. Its main business includes various stapler products in surgical fields such as cardiothoracic surgery, gastrointestinal surgery, hepatobiliary, spleen, and pancreatic surgery, general surgery, and urology. These products include five categories: tubular staplers, endoscopic staplers, linear cutting staplers, pouch staplers, and linear suture staplers. The company is committed to scientific diagnosis, accurate treatment and scientific rehabilitation, and aims to improve the quality of life of patients. In terms of assets and liabilities,
Tesson Healthcare (688013.SH) released the first three quarter results, net profit of 33.1119 million yuan, up 4.15% year on year
Tesson Healthcare (688013.SH) released its report for the first three quarters of 2023, with revenue of 182 million yuan, the same...
Tianson Healthcare (688013.SH): 41.868 million restricted shares will be listed and distributed from September 28
Gelonghui September 20 | Tianchen Healthcare (688013.SH) announced that the restricted shares currently listed are part of the limited initial public offering. A total of 2 shareholders are involved, namely Chen Wangyu and Chen Wangdong. The corresponding number of restricted shares is 41.868 million shares, accounting for 51.59% of the company's current total share capital. The limited sale period for shareholders mentioned above is 36 months from the date the company's first issued shares are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The current sales limit period is about to expire and will be listed and distributed from September 28, 2023.
Tianchen Healthcare (688013.SH): Plans to use no more than 300 million yuan of temporarily idle funds raised for cash management
Glonghui, September 20, 丨 Tianchen Healthcare (688013.SH) announced that on September 20, 2023, the company held the 8th meeting of the 2nd board of directors and the 7th meeting of the 2nd board of supervisors to deliberate and pass the “Proposal on Using Some Temporarily Idle Funds Raised for Cash Management”. It was agreed that the company plans to use no more than RMB 300 million (including principal amount) of temporarily idle funds raised for cash management, and is intended to be used to purchase highly secure, liquid, and capital protected investment products sold by banks or other financial institutions with legal operating qualifications (including but not limited to structures) Sex deposit, agreement deposit, credit card
Tianson Healthcare (688013.SH) released first-half results, with net profit of 26.5896 million yuan, an increase of 39.04% over the previous year
Tianchen Healthcare (688013.SH) released the 2023 semi-annual report. The company's revenue was 127 million yuan,...
Tianchen Healthcare (688013.SH) selected as a national-level specialty new “little giant” enterprise
According to the Zhitong Finance App, Tianchen Healthcare (688013.SH) issued an announcement. On July 14, 2023, the Jiangsu Provincial Department of Industry and Information Technology issued the “Notice Concerning the List of the Fifth Batch of Specialized and Exclusive New “Little Giants” Enterprises in Jiangsu Province and the Second Batch of Specialized Special New “Little Giants” Reviewed Enterprises”. The publication period is from July 14 to July 20, 2023. The company has been selected as the fifth batch of “little giant” companies that specialize in exclusive and exclusive new products, and has already been publicized.
Tianchen Healthcare (688013.SH): Yingjie Healthcare reduced its holdings by a total of 311,500 shares in bulk transactions
On July 7, 2023, Glonway | Tianchen Healthcare (688013.SH) announced that on July 6, 2023, Yingjie Medical Co., Ltd. reduced its holdings of the company's unlimited tradable shares by a total of 3111,500 shares, accounting for 0.3838% of Tianchen Healthcare's total share capital.
Tianchen Healthcare (688013.SH) plans to distribute 2.5 yuan for every 10 shares in 2022, excluding interest on June 27
According to the Zhitong Finance App, Tianchen Healthcare (688013.SH) announced that in 2022, the company plans to distribute a cash dividend of RMB 2.50 (tax included) for every 10 shares to all shareholders registered on the equity registration date. The stock registration date is June 26, 2023, and the deduction date is June 27, 2023.
Analysis
Price Target
No Data
